FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004335060> ?p ?o ?g. }

• W2004335060 endingPage "476" @default.
• W2004335060 startingPage "465" @default.
• W2004335060 abstract "Adenylyl cyclase VI (ACVI) is one of the most abundantly expressed β adrenergic receptor ( β AR)‐coupled cyclases responsible for cyclic AMP (cAMP) production within the mammalian myocardium. We investigated the role of ACVI in the regulation of cardiomyocyte contractility and whether it is functionally coupled with β 1 adrenergic receptor ( β 1 AR). Recombinant adenoviruses were generated for ACVI and for antisense to ACVI (AS). Adult rat ventricular myocytes were transfected with ACVI virus, AS or both (SAS). Adenovirus for green fluorescent protein (GFP) served as control. Myocyte contraction amplitudes (% shortening) and relaxation times (R50) were analysed. ACVI function was determined using cAMP assays. ACVI‐transfected cells demonstrated a strong 139 kDa ACVI protein band compared to controls. ACVI myocytes had higher steady‐state intracellular cAMP levels than GFP myocytes when unstimulated (GFP vs ACVI=6.60±0.98 vs 14.2±2.1 fmol cAMP/viable cell, n =4, P <0.05) and in the presence of 1 μ M isoprenaline or 10 μ M forskolin. ACVI myocytes had increased basal contraction (% shortening: GFP vs ACVI: 1.90±1.36 vs 3.91±2.29, P <0.0001) and decreased basal R50 (GFP vs ACVI: 62.6±24.2 ms ( n =50) vs 45.0±17.2 ms ( n =248), P <0.0001). ACVI myocyte responses were increased for forskolin ( E max : GFP=6.70±1.59 ( n =6); ACVI=9.06±0.69 ( n =14), P <0.01) but not isoprenaline. ACVI myocyte responses were increased ( E max : GFP vs ACVI=3.16±0.77 vs 5.10±0.60, P <0.0001) to xamoterol (a partial β 1 AR‐selective agonist) under β 2 AR blockade (+50 n M ICI 118, 551). AS decreased both control and ACVI‐stimulated xamoterol responses ( E max : AS=2.59±1.42, SAS=1.38±0.5). ACVI response was not mimicked by IBMX. Conversely, response through β 2 adrenergic receptor ( β 2 AR) was decreased in ACVI myocytes. In conclusion, ACVI overexpression constitutively increases myocyte contraction amplitudes by raising cAMP levels. Native ACVI did not contribute to basal cAMP production or contraction amplitude and only to a minor extent to the forskolin response. β 1 AR but not β 2 AR coupling was dependent on ACVI. British Journal of Pharmacology (2004) 143 , 465–476. doi: 10.1038/sj.bjp.0705976" @default.
• W2004335060 created "2016-06-24" @default.
• W2004335060 creator A5005730347 @default.
• W2004335060 creator A5009410142 @default.
• W2004335060 creator A5055266997 @default.
• W2004335060 creator A5067046310 @default.
• W2004335060 creator A5085940065 @default.
• W2004335060 date "2004-10-01" @default.
• W2004335060 modified "2023-10-14" @default.
• W2004335060 title "Effect of overexpressed adenylyl cyclase VI on<i>β</i>₁- and<i>β</i>₂-adrenoceptor responses in adult rat ventricular myocytes" @default.
• W2004335060 cites W15092041 @default.
• W2004335060 cites W1571480579 @default.
• W2004335060 cites W1589589448 @default.
• W2004335060 cites W1967729387 @default.
• W2004335060 cites W1970453709 @default.
• W2004335060 cites W1971072760 @default.
• W2004335060 cites W1972870617 @default.
• W2004335060 cites W1992997162 @default.
• W2004335060 cites W1995261878 @default.
• W2004335060 cites W2004758591 @default.
• W2004335060 cites W2007098938 @default.
• W2004335060 cites W2009291798 @default.
• W2004335060 cites W2015557754 @default.
• W2004335060 cites W2016878695 @default.
• W2004335060 cites W2022707770 @default.
• W2004335060 cites W2022946669 @default.
• W2004335060 cites W2025620168 @default.
• W2004335060 cites W2025929682 @default.
• W2004335060 cites W2032979918 @default.
• W2004335060 cites W2035280604 @default.
• W2004335060 cites W2037946626 @default.
• W2004335060 cites W2041220722 @default.
• W2004335060 cites W2046425717 @default.
• W2004335060 cites W2050168960 @default.
• W2004335060 cites W2066764075 @default.
• W2004335060 cites W2082487445 @default.
• W2004335060 cites W2086652137 @default.
• W2004335060 cites W2086753368 @default.
• W2004335060 cites W2095902402 @default.
• W2004335060 cites W2099757528 @default.
• W2004335060 cites W2107235611 @default.
• W2004335060 cites W2114444523 @default.
• W2004335060 cites W2118300866 @default.
• W2004335060 cites W2138354938 @default.
• W2004335060 cites W2148253066 @default.
• W2004335060 cites W2148535393 @default.
• W2004335060 cites W2151825667 @default.
• W2004335060 cites W2167285355 @default.
• W2004335060 cites W2418779321 @default.
• W2004335060 cites W250216309 @default.
• W2004335060 cites W4229759864 @default.
• W2004335060 cites W4232708797 @default.
• W2004335060 cites W4240676148 @default.
• W2004335060 cites W4245451967 @default.
• W2004335060 cites W4252491329 @default.
• W2004335060 cites W4253778957 @default.
• W2004335060 doi "https://doi.org/10.1038/sj.bjp.0705976" @default.
• W2004335060 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1575419" @default.
• W2004335060 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15381636" @default.
• W2004335060 hasPublicationYear "2004" @default.
• W2004335060 type Work @default.
• W2004335060 sameAs 2004335060 @default.
• W2004335060 citedByCount "6" @default.
• W2004335060 countsByYear W20043350602012 @default.
• W2004335060 countsByYear W20043350602014 @default.
• W2004335060 countsByYear W20043350602020 @default.
• W2004335060 crossrefType "journal-article" @default.
• W2004335060 hasAuthorship W2004335060A5005730347 @default.
• W2004335060 hasAuthorship W2004335060A5009410142 @default.
• W2004335060 hasAuthorship W2004335060A5055266997 @default.
• W2004335060 hasAuthorship W2004335060A5067046310 @default.
• W2004335060 hasAuthorship W2004335060A5085940065 @default.
• W2004335060 hasBestOaLocation W20043350601 @default.
• W2004335060 hasConcept C126322002 @default.
• W2004335060 hasConcept C134018914 @default.
• W2004335060 hasConcept C170493617 @default.
• W2004335060 hasConcept C207200792 @default.
• W2004335060 hasConcept C24998067 @default.
• W2004335060 hasConcept C2776090920 @default.
• W2004335060 hasConcept C2779178603 @default.
• W2004335060 hasConcept C2779276759 @default.
• W2004335060 hasConcept C39133596 @default.
• W2004335060 hasConcept C54009773 @default.
• W2004335060 hasConcept C54355233 @default.
• W2004335060 hasConcept C71924100 @default.
• W2004335060 hasConcept C79879829 @default.
• W2004335060 hasConcept C81885089 @default.
• W2004335060 hasConcept C86803240 @default.
• W2004335060 hasConcept C95444343 @default.
• W2004335060 hasConceptScore W2004335060C126322002 @default.
• W2004335060 hasConceptScore W2004335060C134018914 @default.
• W2004335060 hasConceptScore W2004335060C170493617 @default.
• W2004335060 hasConceptScore W2004335060C207200792 @default.
• W2004335060 hasConceptScore W2004335060C24998067 @default.
• W2004335060 hasConceptScore W2004335060C2776090920 @default.
• W2004335060 hasConceptScore W2004335060C2779178603 @default.
• W2004335060 hasConceptScore W2004335060C2779276759 @default.
• W2004335060 hasConceptScore W2004335060C39133596 @default.

• next